SBC Medical Joins Russell 3000 Index June 2025

The latest announcement is out from SBC Medical Group Holdings ( (SBC) ).

On June 27, 2025, SBC Medical Group Holdings announced its inclusion in the Russell 3000® Index, effective June 30, 2025, as part of the 2025 Russell indexes reconstitution. This inclusion signifies automatic membership in either the large-cap Russell 1000® Index or the small-cap Russell 2000® Index, enhancing the company’s visibility among investment managers and institutional investors who use these indexes as benchmarks for active investment strategies. This development is expected to positively impact SBC Medical’s market positioning by aligning it with approximately $10.6 trillion in assets benchmarked against the Russell US indexes.

Spark’s Take on SBC Stock

According to Spark, TipRanks’ AI Analyst, SBC is a Outperform.

SBC’s strong financial performance, characterized by robust growth and profitability, significantly contributes to its overall score. Technical analysis indicates moderate positive momentum, and valuation metrics suggest the stock is fairly valued. Cash flow management remains an area for potential improvement.

To see Spark’s full report on SBC stock, click here.

More about SBC Medical Group Holdings

SBC Medical Group Holdings Incorporated, headquartered in Irvine, California, and Tokyo, Japan, is a global franchise and provider of services for aesthetic clinics. The company focuses on offering comprehensive management services to franchisee clinics, including advertising, staff management, booking reservations, facility rentals, and procurement of medical equipment and consumables. Additionally, SBC Medical provides cosmetic products for resale, licenses medical technologies, and offers IT solutions such as remote medical consultations.

Average Trading Volume: 83,084

Technical Sentiment Signal: Sell

Current Market Cap: $480.8M

For an in-depth examination of SBC stock, go to TipRanks’ Overview page.